Bayer AG has agreed on draft settlement terms with half a dozen law firms representing tens of thousands of plaintiffs alleging that the company's Roundup weedkiller causes cancer, pushing the litigation closer to a final resolution, according to people familiar with the matter.
The six big firms speak on behalf of dozens of firms that represent a large chunk of the plaintiffs suing Bayer, the people said. Bayer is striving to find a way to both keep Roundup on consumer shelves and end litigation that significantly damaged its share price following the loss of three jury trials in the U.S.
For weeks, Bayer and plaintiffs attorneys have been discussing a settlement in the $10 billion range, The Wall Street Journal has reported, citing people familiar with the matter. One person said the deal still appears poised to end up around that number, though the people cautioned that a formal deal hasn't been signed and could yet fall apart.
Parties on both sides are free to walk away from the agreements, and Bayer has said that protecting itself from future litigation is a condition of any settlement.
The parties could reach a final agreement in the coming weeks, the people said. RTRS